Chang, Enoch http://orcid.org/0000-0002-2879-5445
Mougalian, Sarah S.
Adelson, Kerin B.
Young, Melissa R.
Yu, James B.
Funding for this research was provided by:
National Institutes of Health (T35DK104689)
Article History
Received: 26 July 2018
Accepted: 12 September 2018
First Online: 21 September 2018
Compliance with ethical standards
:
: Sarah S. Mougalian MD: Consulting role with Eisai. Stocks: Gilead, Coronado Biosciences, Roche. Research funding from Genentech, Pfizer; Kerin B. Adelson MD: Immediate family member is employed with Lyra Health; Consulting role with Wellpoint; Travel, Accommodations, Expenses from Genentech; Honoraria from Genentech; James B. Yu MD, MHS: Consulting role with Augmenix. Research funding from twenty-first Century Oncology.